GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelira Therapeutics Ltd (ASX:ZLD) » Definitions » Growth Rank

Zelira Therapeutics (ASX:ZLD) Growth Rank : 0 (As of Jun. 24, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Zelira Therapeutics Growth Rank?

Zelira Therapeutics has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Zelira Therapeutics Growth Rank Related Terms

Thank you for viewing the detailed overview of Zelira Therapeutics's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Zelira Therapeutics (ASX:ZLD) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelira Therapeutics Ltd (ASX:ZLD) » Definitions » Growth Rank
Comparable Companies
ASX:NSB ASX:IXC ASX:CMB ASX:VBS ASX:ILA ASX:ANR ASX:HXL ASX:AVE ASX:NYR ASX:MEM OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
ZLDAF:USA G1G:Germany
Address
101 St George’s Terrace, Level 3, Perth, WA, AUS, 6000
Website
https://www.zeliratx.com
Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer.

Zelira Therapeutics (ASX:ZLD) Headlines

No Headlines